Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: A case report and literature review

Jingping Yuan, Liang He, Bing Han, Yan Li

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation: We report here a long-term survival case of PPPSC with postoperative lung metastasis. A 62-year-old female patient with PPPSC was administered two cycles of neoadjuvant chemotherapy (NAC) followed by cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) and six cycles of platinum-based (docetaxel + carboplatin) intraperitoneal chemotherapy postoperatively. The patient reached a complete remission at the completion of primary treatment. Malignant thoracic effusion and lung metastasis developed 5 months after the treatment. The patient underwent video-assisted thoracoscopic surgery plus hyperthermic intrapleural chemotherapy. Conclusions: Up to present, the patient has been survived with tumor for over 86 months with a good performance status, with only encapsulated effusion found at the latest follow-up. As a relatively new regime, the application of CRS + HIPEC in our patient has been proved example for MPE management, although more large-scale studies are needed to substantiate its efficiency and safety.

Original languageEnglish (US)
Article number76
JournalWorld Journal of Surgical Oncology
Volume15
Issue number1
DOIs
StatePublished - Apr 11 2017

Fingerprint

Papillary Adenocarcinoma
Papillary Carcinoma
Drug Therapy
Survival
docetaxel
Neoplasm Metastasis
Video-Assisted Thoracic Surgery
Lung
Carboplatin
Platinum
Neoplasms
Thorax
Safety
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

@article{0f688ff043e54d67a3e19cd04b904506,
title = "Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: A case report and literature review",
abstract = "Background: Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation: We report here a long-term survival case of PPPSC with postoperative lung metastasis. A 62-year-old female patient with PPPSC was administered two cycles of neoadjuvant chemotherapy (NAC) followed by cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) and six cycles of platinum-based (docetaxel + carboplatin) intraperitoneal chemotherapy postoperatively. The patient reached a complete remission at the completion of primary treatment. Malignant thoracic effusion and lung metastasis developed 5 months after the treatment. The patient underwent video-assisted thoracoscopic surgery plus hyperthermic intrapleural chemotherapy. Conclusions: Up to present, the patient has been survived with tumor for over 86 months with a good performance status, with only encapsulated effusion found at the latest follow-up. As a relatively new regime, the application of CRS + HIPEC in our patient has been proved example for MPE management, although more large-scale studies are needed to substantiate its efficiency and safety.",
author = "Jingping Yuan and Liang He and Bing Han and Yan Li",
year = "2017",
month = "4",
day = "11",
doi = "10.1186/s12957-017-1134-3",
language = "English (US)",
volume = "15",
journal = "World Journal of Surgical Oncology",
issn = "1477-7819",
publisher = "BioMed Central",
number = "1",

}

Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma : A case report and literature review. / Yuan, Jingping; He, Liang; Han, Bing; Li, Yan.

In: World Journal of Surgical Oncology, Vol. 15, No. 1, 76, 11.04.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma

T2 - A case report and literature review

AU - Yuan, Jingping

AU - He, Liang

AU - Han, Bing

AU - Li, Yan

PY - 2017/4/11

Y1 - 2017/4/11

N2 - Background: Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation: We report here a long-term survival case of PPPSC with postoperative lung metastasis. A 62-year-old female patient with PPPSC was administered two cycles of neoadjuvant chemotherapy (NAC) followed by cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) and six cycles of platinum-based (docetaxel + carboplatin) intraperitoneal chemotherapy postoperatively. The patient reached a complete remission at the completion of primary treatment. Malignant thoracic effusion and lung metastasis developed 5 months after the treatment. The patient underwent video-assisted thoracoscopic surgery plus hyperthermic intrapleural chemotherapy. Conclusions: Up to present, the patient has been survived with tumor for over 86 months with a good performance status, with only encapsulated effusion found at the latest follow-up. As a relatively new regime, the application of CRS + HIPEC in our patient has been proved example for MPE management, although more large-scale studies are needed to substantiate its efficiency and safety.

AB - Background: Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation: We report here a long-term survival case of PPPSC with postoperative lung metastasis. A 62-year-old female patient with PPPSC was administered two cycles of neoadjuvant chemotherapy (NAC) followed by cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) and six cycles of platinum-based (docetaxel + carboplatin) intraperitoneal chemotherapy postoperatively. The patient reached a complete remission at the completion of primary treatment. Malignant thoracic effusion and lung metastasis developed 5 months after the treatment. The patient underwent video-assisted thoracoscopic surgery plus hyperthermic intrapleural chemotherapy. Conclusions: Up to present, the patient has been survived with tumor for over 86 months with a good performance status, with only encapsulated effusion found at the latest follow-up. As a relatively new regime, the application of CRS + HIPEC in our patient has been proved example for MPE management, although more large-scale studies are needed to substantiate its efficiency and safety.

UR - http://www.scopus.com/inward/record.url?scp=85018525630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018525630&partnerID=8YFLogxK

U2 - 10.1186/s12957-017-1134-3

DO - 10.1186/s12957-017-1134-3

M3 - Article

C2 - 28399919

AN - SCOPUS:85018525630

VL - 15

JO - World Journal of Surgical Oncology

JF - World Journal of Surgical Oncology

SN - 1477-7819

IS - 1

M1 - 76

ER -